Steven Epstein

Steven Epstein is a trusted advisor to some of the country’s leading companies across a broad range of industry sectors. As co-head of our Mergers & Acquisitions Practice, Steve counsels public and private companies, financial sponsors, and investment banking firms in a variety of transactional and advisory situations, including acquisitions, divestitures, takeover preparedness, and corporate governance matters. Steve brings extensive knowledge and experience from different deal-making perspectives, having advised clients both as an attorney and, previously, as an investment banker at Credit Suisse.

Steve’s outstanding practice has earned him accolades from Chambers USA: America's Leading Lawyers for Business as a leading individual in Corporate/M&A, Legal 500 in M&A, and Super Lawyers. He was named a BTI “Client Service All-Star” for 2020 and 2021 and has been recognized since 2015 in the NACD’s “Directorship 100” as a leading advisor to corporate boards. He was previously named a Rockefeller Fellow by the Partnership for New York City.

Sought after as a thought leader in the space, Steve speaks frequently and writes extensively on developments in M&A and on emerging corporate governance trends.

Work highlights:

• Leidos Holdings in its $1 billion acquisition of L3Harris' Security, Detection, and Automation business, and in the $170 million sale of its commercial cybersecurity business to Capgemini America, Inc.
• Catalent in numerous engagements including its $1b acquisition of Bettera Holdings, its $1.2 billion acquisition of Paragon Bioservices, its $950 million acquisition of Cook Pharmica, its $475 million acquisition of Metrics Contract Services, and its acquisitions of Redwood Bioscience, Micron Technologies, Accucaps Industries Limited, MaSTherCell Global and Vaccine Manufacturing and Innovation Centre UK Limited
• W.R. Grace in numerous engagements including its $500 million acquisition of the UNIPOL Polypropylene Licensing and Catalysts business of The Dow Chemical Company, its $416 million acquisition of the polyolefin catalysts business of Albemarle Corporation, and its acquisition of BASF's polyolefin catalyst business
• Apollo Global Management in numerous engagements, including advising the special committee of the board of directors of Apollo Commercial Real Estate Finance in its $641 million acquisition of Apollo Residential Mortgage
• Becton, Dickinson and Company in numerous engagements including its acquisitions of TVA Medical, Scanwell Health Inc., ZebraSci, Inc., and Tepha, Inc.